发明名称 3-Substituted-4-pyrimidone derivatives
摘要 A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.
申请公布号 US7572793(B2) 申请公布日期 2009.08.11
申请号 US20050489607 申请日期 2005.02.08
申请人 MITSUBISHI TANABE PHARMA CORPORATION;SANOFI-AVENTIS 发明人 UEHARA FUMIAKI;ARITOMO KEIICHI;SHODA AYA;HIKI SHINSUKE;OKUYAMA MASAHIRO;USUI YOSHIHIRO;OOIZUMI MITSURU;WATANABE KAZUTOSHI
分类号 A61K31/535;C07D239/36;A61K31/513;A61K31/5377;A61K31/5386;A61K31/54;A61P3/04;A61P3/10;A61P17/14;A61P25/02;A61P25/16;A61P25/18;A61P25/28;A61P27/02;A61P27/06;A61P35/00;A61P35/02;A61P43/00;C07D237/02;C07D239/34;C07D239/40;C07D239/46;C07D239/56;C07D265/30;C07D295/00;C07D401/04;C07D401/14;C07D403/00;C07D413/00;C07D413/04;C07D413/14;C07D417/14;C07D498/10 主分类号 A61K31/535
代理机构 代理人
主权项
地址